Brookshire Cypress Jersey Village Katy
1.9K Reviews    |    4.7 Star Rating    |    20+ years of experience    |    75k+ Patients Treated
Call

Hepatomegaly Sensation / Fullness in RUQ Patient Journey in Houston, TX

How do clinicians confirm whether the liver is enlarged, distinguish diffuse enlargement from cysts or a focal mass, identify metabolic, viral, cardiac, infiltrative, or malignant causes, and separate liver disease from gallbladder or other right-upper-abdominal mimics?

Monica’s path from increasing RUQ fullness, early satiety, unintended weight loss, fatigue, and a new firm area beneath the ribs to hepatocellular carcinoma in a cirrhotic liver, targeted care, and documented follow-up

Medically reviewed by: Dr. Bharat Pothuri, MD, FACG Specialty: Gastroenterology & Hepatology Last updated: 2026-08-17

GastroDoxs GutGuardians™

Your guardians. GastroDoxs GutGuardians™ is our team of board-certified gastroenterologists - a physician-led defense force of specialists, systems, and solution pathways working together to protect, detect, solve, and defend your digestive health through expert GI evaluation, advanced diagnostic screening, and endoscopic evaluation - commanded from your first concern to your last follow-up, and every critical stage in between.

Monica’s Story: Hepatocellular carcinoma detected after increasing RUQ fullness and abnormal surveillance imaging

A 63-year-old former procurement analyst with cirrhosis looking for an explanation for increasing RUQ fullness, early satiety, unintended weight loss, fatigue, and a new firm area beneath the ribs

Monica was a former procurement analyst with cirrhosis whose first explanation was progressive bloating from ascites.

The decision changed when weight loss and a new focal lesion appeared during surveillance. The combination of increasing RUQ fullness, early satiety, unintended weight loss, fatigue, and a new firm area beneath the ribs required a more specific evaluation.

Surveillance ultrasound showed a new lesion. Multiphase liver-protocol MRI demonstrated a characteristic enhancement pattern in cirrhosis, and multidisciplinary review established hepatocellular carcinoma stage without relying on symptoms or AFP alone.

The final plan used multidisciplinary stage-based treatment using resection, transplant evaluation, ablation, radiation, embolization, or systemic therapy according to tumor burden and liver reserve. Follow-up measured safety, symptom resolution, objective recovery, and the risk of recurrence.

The change on surveillance imaging—not fullness alone—defined the liver-cancer pathway and treatment options.

The First Signs: How Monica’s Symptoms Began

Monica first noticed increasing RUQ fullness and assumed progressive bloating from ascites.

Additional symptoms developed: increasing RUQ fullness, early satiety, unintended weight loss, fatigue, and a new firm area beneath the ribs.

The pattern became harder to dismiss when weight loss and a new focal lesion appeared during surveillance.

That change led to testing selected for hepatocellular carcinoma in a cirrhotic liver rather than another round of symptom-only treatment.

When Monica Understood What Had Changed

The turning point was replacing the assumption of progressive bloating from ascites with evidence supporting hepatocellular carcinoma in a cirrhotic liver.

At first, Monica tried to fit the symptoms into a familiar explanation.

The pattern no longer fit when weight loss and a new focal lesion appeared during surveillance.

Surveillance ultrasound showed a new lesion. Multiphase liver-protocol MRI demonstrated a characteristic enhancement pattern in cirrhosis, and multidisciplinary review established hepatocellular carcinoma stage without relying on symptoms or AFP alone.

The team explained why multidisciplinary stage-based treatment using resection, transplant evaluation, ablation, radiation, embolization, or systemic therapy according to tumor burden and liver reserve addressed the supported mechanism and what findings would require escalation.

That explanation turned several disconnected tests and recommendations into one coherent care path.

Uncertainty Became a Defined Question

Testing focused on confirming or excluding hepatocellular carcinoma in a cirrhotic liver.

Urgency Was Matched to Risk

The care setting reflected bleeding, obstruction, infection, ischemia, perforation, and clinical stability.

Follow-Up Had an Endpoint

Symptoms, laboratory recovery, imaging, endoscopy, pathology, or postoperative milestones were used as appropriate.

Why Monica Needed More Than Symptom-Only Treatment

The record required one interpretation that connected the symptom pattern, diagnostic evidence, immediate risks, treatment mechanism, and follow-up endpoint.

The Initial Explanation Was Incomplete

The assumption of progressive bloating from ascites no longer accounted for the full pattern.

Objective Evidence Changed the Differential

The team considered MASLD or MASH, alcohol-related disease, viral and autoimmune hepatitis, congestive hepatopathy, biliary obstruction, cystic and infiltrative disease, benign and malignant masses, gallbladder disease, gastric or colonic fullness, lung disease, and abdominal-wall pain.

Treatment Needed a Supported Target

The plan focused on hepatocellular carcinoma in a cirrhotic liver rather than the symptom label alone.

Recovery Needed Measurement

The team defined symptom, laboratory, imaging, endoscopic, pathology, or postoperative endpoints appropriate to the case.

A Symptom Pattern Needs a Cause, a Safety Assessment, and a Follow-Up Endpoint

GastroDoxs can evaluate stable RUQ fullness, confirm whether hepatomegaly is present, interpret liver and imaging patterns, and coordinate cause-directed care. Jaundice, fever, severe pain, confusion, bleeding, or rapid swelling requires urgent care.

How Monica’s Symptoms Led to Cause-Directed Care

The sequence moved from a nonspecific complaint to risk assessment, targeted testing, a supported diagnosis, treatment matched to the mechanism, and documented follow-up.

Testing Defines the Problem

Surveillance ultrasound showed a new lesion. Multiphase liver-protocol MRI demonstrated a characteristic enhancement pattern in cirrhosis, and multidisciplinary review established hepatocellular carcinoma stage without relying on symptoms or AFP alone.

Review Hepatomegaly Sensation / Fullness in RUQ →

The Mechanism Directs Treatment

The supported pattern was hepatocellular carcinoma in a cirrhotic liver, so the plan used multidisciplinary stage-based treatment using resection, transplant evaluation, ablation, radiation, embolization, or systemic therapy according to tumor burden and liver reserve.

Review the treatment guide →

Follow-Up Measures Recovery

Monica entered treatment while disease remained potentially controllable, with nutrition, portal-hypertension, and cirrhosis care continuing alongside oncology.

Schedule An Evaluation →

Decisions That Shaped Monica’s Evaluation

The first decisions are whether the fullness reflects true liver enlargement, whether jaundice or fever indicates inflammation or obstruction, whether heart failure is causing venous congestion, whether a focal mass needs liver-protocol imaging, and whether symptoms actually arise from the gallbladder or another organ.

Confirm the Anatomy

Examination and ultrasound determine liver size, surface, texture, focal lesions, bile ducts, gallbladder, spleen, vessels, and fluid.

Define the Laboratory Pattern

AST, ALT, alkaline phosphatase, bilirubin, albumin, INR, CBC, platelets, and renal tests distinguish injury, cholestasis, function, and portal effects.

Match Causes to Risk

Metabolic factors, alcohol, medicines, viral exposure, autoimmunity, heart disease, cancer history, and family cystic disease direct testing.

Characterize Focal Findings

Liver-protocol CT or MRI evaluates a mass or complex cyst rather than relying on a nonspecific ultrasound label.

Measure Fibrosis and Complications

FIB-4, elastography, portal findings, surveillance eligibility, and selected biopsy answer questions that change prognosis or treatment.

Severe or rapidly worsening RUQ pain, fever or chills, jaundice, confusion, fainting, vomiting blood, black stool, persistent vomiting, shortness of breath, new major abdominal or leg swelling, or rapidly worsening weakness requires urgent assessment.

How Clinicians Interpreted Monica’s Hepatocellular Carcinoma in Cirrhosis

RUQ fullness is interpreted by connecting physical findings, liver size and texture, focal versus diffuse imaging, hepatocellular versus cholestatic laboratory patterns, synthetic function, portal hypertension, cardiac congestion, metabolic and viral risks, and nonhepatic alternatives.

Hepatomegaly Is a Finding

An enlarged liver is not a final diagnosis; the distribution, tissue pattern, laboratory results, and clinical setting identify the mechanism.

Steatosis Does Not Stage Fibrosis

Routine imaging can show liver fat but cannot reliably distinguish simple steatosis from steatohepatitis or define fibrosis severity.

Congestion Can Enlarge the Liver

Right-sided heart pressure can produce a tender enlarged liver, pulsatility, edema, ascites, and abnormal liver tests.

A Mass Requires Dedicated Characterization

Risk factors, multiphase enhancement, AFP in context, prior imaging, and multidisciplinary review guide HCC or metastatic evaluation.

Hepatocellular Carcinoma in Cirrhosis

Surveillance ultrasound showed a new lesion. Multiphase liver-protocol MRI demonstrated a characteristic enhancement pattern in cirrhosis, and multidisciplinary review established hepatocellular carcinoma stage without relying on symptoms or AFP alone.

What Happened During Monica’s Stable GI Review

A stable visit maps fullness duration, pain, meal and movement relation, jaundice, stool and urine color, weight, fever, swelling, breathlessness, alcohol, medicines, metabolic and viral risk, heart disease, family history, laboratory trends, and all prior liver and gallbladder images.

Symptom and Examination Map

Define fullness versus pain, tenderness, palpable edge, abdominal wall features, ascites, spleen, edema, and cardiopulmonary signs.

Liver Laboratory Review

Compare injury, cholestasis, bilirubin, albumin, INR, platelets, renal function, and trends rather than labeling one enzyme result.

Ultrasound and Image Reconciliation

Confirm measurements, steatosis, cysts, masses, ducts, vessels, gallbladder, spleen, and fluid on the original report and images when available.

Cause-Specific Testing

Select viral, autoimmune, iron, cardiac, metabolic, genetic, or oncologic studies from the actual risk pattern.

A Measurable Endpoint

Track symptoms, liver tests, size or lesion imaging, fibrosis risk, cardiac volume status, nutrition, and surveillance needs.

From Hepatocellular Carcinoma in Cirrhosis to a Defined Care Plan

Treatment targets the cause of enlargement or the true source of fullness. Plans may address metabolic liver disease, alcohol, viral hepatitis, heart failure, biliary disease, symptomatic cyst burden, a focal tumor, or a nonhepatic mimic while monitoring liver function and fibrosis.

Treat Metabolic Liver Risk

Use sustainable weight, nutrition, activity, diabetes, lipid, and blood-pressure management with fibrosis-based follow-up.

Remove Hepatic Injury

Coordinate alcohol cessation, antiviral therapy, autoimmune treatment, or medication changes when supported.

Relieve Venous Congestion

Cardiac therapy and careful volume management address congestive hepatopathy rather than liver-directed treatment alone.

Manage Cysts or Masses Selectively

Observation, interventional treatment, surgery, transplant review, or oncology care depends on symptoms, anatomy, diagnosis, and liver reserve.

Treat the Mimic

Gallbladder, stomach, colon, lung, or abdominal-wall disease receives its own pathway when liver size and testing are normal.

How the Pathway Applied to Monica

For this composite, the plan used multidisciplinary stage-based treatment using resection, transplant evaluation, ablation, radiation, embolization, or systemic therapy according to tumor burden and liver reserve. The result was measured through this outcome: Monica entered treatment while disease remained potentially controllable, with nutrition, portal-hypertension, and cirrhosis care continuing alongside oncology.

Why Houston, TX Patients Benefit From Coordinated Records and Follow-Up

The Houston, TX plan linked the original acute or diagnostic setting with gastroenterology, radiology, pathology, surgery, primary care, and other services needed for hepatocellular carcinoma in a cirrhotic liver.

One Diagnostic Record

The Houston, TX review reconciled imaging, endoscopy, pathology, laboratory trends, and treatment response.

Urgency Remained Explicit

The Houston, TX office handled stable review; active emergency warning signs returned to hospital-level care.

Specialists Had Defined Questions

Radiology, pathology, surgery, pelvic-floor, vascular, infectious-disease, or IBD input was requested only when it could change the plan.

Follow-Up Used Measurable Endpoints

The Houston, TX baseline allowed symptoms, blood counts, imaging, mucosal findings, or postoperative milestones to be compared over time.

GastroDoxs RUQ Fullness and Liver Liver And Ruq Symptom Evaluation for Houston, TX

GastroDoxs can evaluate stable RUQ fullness, confirm whether hepatomegaly is present, interpret liver and imaging patterns, and coordinate cause-directed care. Jaundice, fever, severe pain, confusion, bleeding, or rapid swelling requires urgent care.

Address

HCA North Cypress, Doctors' Pavilion, 10425 Huffmeister Road, Suite 280, Houston, TX 77065

Office Hours

Monday through Friday, 7:00 AM to 7:00 PM

Areas Served

Houston, Bear Creek, Spring Branch, Copperfield, Willowbrook, and northwest Houston

Main Access Routes

Huffmeister Road, Beltway 8, Highway 6, and US-290

Planning RUQ Fullness and Liver Evaluation and Follow-Up

Coverage can differ for liver and blood testing, ultrasound, elastography, CT or MRI, viral and autoimmune studies, echocardiography, liver-protocol imaging, biopsy, cyst intervention, oncology care, and surveillance.

Confirm the Care Setting

Ask whether the planned service belongs in an office, endoscopy center, radiology department, hospital, infusion site, or surgical facility.

Verify Diagnostic Coverage

Imaging, endoscopy, pathology, capsule, functional testing, or specialist review may have separate authorization and cost-sharing rules.

Send Existing Records First

Prior images, pathology, operative notes, and laboratory trends can prevent unnecessary repetition and clarify the correct next service.

Do Not Delay Emergency Care

Coverage questions should never postpone evaluation of severe pain, major bleeding, persistent vomiting, sepsis signs, or bowel obstruction.

Why Monica Chose the Final Care Strategy

The selected plan matched diagnostic certainty, immediate risk, anatomy, the supported mechanism, prior response, and the least invasive option likely to be safe and effective.

The Pattern Was Supported

Surveillance ultrasound showed a new lesion. Multiphase liver-protocol MRI demonstrated a characteristic enhancement pattern in cirrhosis, and multidisciplinary review established hepatocellular carcinoma stage without relying on symptoms or AFP alone.

The Risks Were Defined

The team considered MASLD or MASH, alcohol-related disease, viral and autoimmune hepatitis, congestive hepatopathy, biliary obstruction, cystic and infiltrative disease, benign and malignant masses, gallbladder disease, gastric or colonic fullness, lung disease, and abdominal-wall pain.

Treatment Matched the Cause

The plan used multidisciplinary stage-based treatment using resection, transplant evaluation, ablation, radiation, embolization, or systemic therapy according to tumor burden and liver reserve.

Escalation Criteria Were Explicit

New or worsening warning signs, failure to improve, objective recurrence, or a new structural concern triggered reassessment.

Diffuse Liver Enlargement, Focal Lesion, Congestion, and RUQ-Mimic Pathways

The pathway depends on diffuse versus focal imaging, liver-test pattern, fibrosis and function, cardiac findings, fever or jaundice, weight change, and evidence that another right-upper-abdominal organ is responsible.

Diffuse Metabolic or Inflammatory Pathway

Stage fibrosis and treat the supported metabolic, alcohol, viral, or immune cause.

Best for: Diffuse enlargement or steatosis with risk factors

Limitations: Size and enzymes do not define fibrosis

Takeaway: Treat cause and stage separately

Congestive Pathway

Coordinate cardiac assessment and volume management.

Best for: Edema, breathlessness, elevated venous pressure, pulsatile or tender liver

Limitations: Aggressive diuresis may affect kidneys

Takeaway: Treat the heart-liver connection

Focal Lesion Pathway

Use liver-protocol CT or MRI and multidisciplinary review.

Best for: Mass, complex cyst, cirrhosis, hepatitis B, or cancer history

Limitations: Biopsy is not automatically the first step

Takeaway: Characterize before intervening

Nonhepatic RUQ Pathway

Evaluate gallbladder, stomach, colon, lung, and abdominal wall.

Best for: Normal liver size with meal, movement, bowel, or respiratory clues

Limitations: Symptoms can overlap

Takeaway: Do not force a liver diagnosis

When Symptoms Associated With Hepatomegaly Sensation / Fullness in RUQ Need Prompt or Emergency Care

These warning signs can indicate acute hepatitis, biliary infection or obstruction, liver decompensation, major bleeding, severe cardiac congestion, tumor complication, sepsis, or another time-sensitive abdominal diagnosis.

Severe, constant, or rapidly worsening right-upper-abdominal pain
Fever, shaking chills, or rapidly worsening weakness
New or rapidly worsening jaundice, dark urine, or pale stool
Confusion, unusual sleepiness, personality change, or inability to stay awake
Vomiting blood, coffee-ground material, black stool, or heavy rectal bleeding
Persistent vomiting or inability to keep fluids down
Shortness of breath, chest pain, fainting, or new major leg swelling
Rapidly increasing abdominal size, tense swelling, or severe tenderness
Unintended weight loss, a new palpable mass, or rapidly increasing fullness
Very low urine output, low blood pressure, or signs of shock

Monica’s Life After a Cause-Directed Plan

How care for hepatocellular carcinoma in a cirrhotic liver changed symptoms, safety, and follow-up

Monica entered treatment while disease remained potentially controllable, with nutrition, portal-hypertension, and cirrhosis care continuing alongside oncology.

The result followed multidisciplinary stage-based treatment using resection, transplant evaluation, ablation, radiation, embolization, or systemic therapy according to tumor burden and liver reserve.

Follow-up did not rely on symptom improvement alone; relevant blood counts, nutrition, inflammatory markers, imaging, endoscopy, pathology, bowel function, or postoperative findings were considered.

Monica understood which recurrence patterns could use planned review and which warning signs required emergency assessment.

The record preserved the diagnostic reasoning so future clinicians could distinguish a known recurrence from a new and unrelated GI problem.

The change on surveillance imaging—not fullness alone—defined the liver-cancer pathway and treatment options.
Educational Disclaimer

This educational composite illustrates hepatocellular carcinoma detected after increasing RUQ fullness and abnormal surveillance imaging. It does not represent a specific patient, establish a diagnosis, or promise a result. Severe or rapidly worsening RUQ pain, fever or chills, jaundice, confusion, fainting, vomiting blood, black stool, persistent vomiting, shortness of breath, new major abdominal or leg swelling, or rapidly worsening weakness requires urgent assessment.

Hepatomegaly Sensation / Fullness in RUQ FAQs in Houston, TX

Answers about causes, diagnostic testing, treatment choices, complications, follow-up, office access, and urgent warning signs

In Houston, TX, Monica’s evaluation supported hepatocellular carcinoma in a cirrhotic liver. The conclusion used examination, liver and blood tests, ultrasound, targeted CT or MRI, cardiac assessment, and disease-specific testing rather than sensation alone.

No. A Houston, TX patient may feel fullness from the liver, gallbladder, stomach, colon, abdominal wall, lung, or fluid accumulation. Examination and imaging confirm whether the liver is actually enlarged.

Causes in a Houston, TX patient include steatotic liver disease, alcohol, viral or autoimmune hepatitis, venous congestion from heart disease, cysts, infiltrative disorders, storage disease, benign masses, and cancer.

The Houston, TX workup used liver function and blood counts, AFP in context, liver-protocol multiphase CT or MRI, chest and vascular staging as indicated, portal and performance assessment, and biopsy only when imaging and clinical criteria did not establish diagnosis. Testing is matched to the suspected cause and whether jaundice, heart failure, infection, a focal mass, fibrosis, or liver-function loss is present.

Yes. Liver enzymes can be normal in steatotic liver disease, cystic disease, congestion, infiltrative conditions, or even advanced chronic disease. A Houston, TX evaluation interprets laboratory results with imaging and clinical context.

Often. Ultrasound can confirm liver size and assess texture, cysts, bile ducts, gallbladder, vessels, and fluid in a Houston, TX patient. CT or MRI may be needed for a focal lesion, complex cysts, or vascular questions.

The Houston, TX plan used multidisciplinary stage-based treatment using resection, transplant evaluation, ablation, radiation, embolization, or systemic therapy according to tumor burden and liver reserve. Treatment targeted the supported metabolic, cardiac, viral, cystic, malignant, or nonhepatic cause rather than trying to reduce liver size without a diagnosis.

It can, but most enlarged livers in Houston, TX are not caused by cancer. A new focal mass, cirrhosis, hepatitis B, weight loss, rapidly increasing fullness, or abnormal surveillance imaging requires expedited liver-protocol evaluation.

GastroDoxs evaluates stable RUQ fullness and suspected liver enlargement for Houston, TX patients at HCA North Cypress, Doctors' Pavilion, 10425 Huffmeister Road, Suite 280, Houston, TX 77065. Office hours are Monday through Friday, 7:00 AM to 7:00 PM.

A Houston, TX patient should seek urgent care for severe or rapidly worsening pain, fever or chills, jaundice, confusion, fainting, vomiting blood, black stool, persistent vomiting, shortness of breath, new major swelling, or rapidly worsening weakness.

GastroDoxs GutHero Quest™

  1. 1

    Confirm Liver Size

    Use examination and imaging to distinguish true hepatomegaly from a perceived RUQ sensation.

  2. 2

    Classify the Pattern

    Separate diffuse enlargement, congestion, cystic disease, focal mass, and nonhepatic causes.

  3. 3

    Measure Injury and Function

    Review liver-test pattern, bilirubin, albumin, INR, platelets, kidneys, and portal findings.

  4. 4

    Test the Leading Cause

    Use metabolic, viral, autoimmune, cardiac, genetic, or oncologic testing selectively.

  5. 5

    Treat the Mechanism

    Address liver disease, cardiac congestion, cyst or tumor anatomy, biliary disease, or another RUQ source.

  6. 6

    Track Recovery and Surveillance

    Measure symptoms, laboratory trends, fibrosis, imaging change, function, and screening needs.

Need a RUQ Fullness and Liver Review in Houston, TX?

GastroDoxs can evaluate stable RUQ fullness, confirm whether hepatomegaly is present, interpret liver and imaging patterns, and coordinate cause-directed care. Jaundice, fever, severe pain, confusion, bleeding, or rapid swelling requires urgent care. Stable review is available in Houston, TX.